| COVID-19 |
1 |
1 |
| COVID-19 Treatment |
0 |
0.71 |
| Referral |
0 |
0.58 |
| Monoclonal Antibody |
0 |
0.5 |
| Preventive Screening |
0 |
0.41 |
| Pandemic |
0 |
0.33 |
| Biologic Therapy |
0 |
0.27 |
| Clinical Research |
0 |
0.17 |
| Health Administration |
0 |
0.17 |
| Primary Care |
0 |
0.17 |
| Erectile Dysfunction |
0 |
0.08 |
| Food and Drug Administration (FDA) |
0 |
0.08 |
| Georgia |
0 |
0.08 |
| Health Care Inequities |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Hypertension |
0 |
0.08 |
| Immunocompromise |
0 |
0.08 |
| Inpatient Care |
0 |
0.08 |
| Outpatient Clinic |
0 |
0.08 |
| Polymerase Chain Reaction |
0 |
0.08 |
| Transplant Evaluation |
0 |
0.08 |